Investor Presentaiton
•
IONM Market Overview
What
Real time observation & analysis of neural
structures during surgery
IONM regarded as standard of care in the
U.S.
Est. $2B U.S. market growing at 10%
Why
• Immediate feedback to a surgeon before
neurological deficits or injury
•
•
Reduces surgical complications
Saves healthcare system money
Improves patient outcomes
.
.
When
Neurosurgeries, spine, vascular, ENT,
orthopedic & other invasive surgeries
Expanding geriatric population &
increasing chronic diseases
• Growth in number of surgeries
•
Highly fragmented industry
Assure Managed Cases*
Rapidly growing volume of cases managed
3,000
2018
Assure 5-Year CAGR = ~63%
21,600
17,400
6,400
9,900
ill
* See Safe Harbor for definition of managed cases
2019
2020
2021
2022
Assure Neuromonitoring | 6View entire presentation